Dynavax appoints Joseph Metzinger as VP and Chief Accounting Officer

DYNAVAX TECHNOLOGIES CORP

Appointment effective May 12, 2025; Metzinger becomes principal accounting officer.
Annual base salary of $315,000 with bonus eligibility up to 40% of base salary.
Granted 38,182 RSUs and 31,500 stock options, each vesting over three years.
Metzinger had served as a consultant to Dynavax since 2024; prior roles include CAO at a public biotech.
Kelly MacDonald remains Senior VP, CFO and principal financial officer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Joseph Metzinger

Vice President, Chief Accounting Officer

DYNAVAX TECHNOLOGIES CORP

Effective: 2025-05-12
Filed: May 13, 2025, 7:59 PM ET

On May 8, 2025, the Board of Directors of Dynavax Technologies Corporation (the “Company”) appointed Joseph Metzinger as the Company’s Vice President, Chief Accounting Officer, effective as of May 12, 2025 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Joseph Metzinger was appointed as Vice President, Chief Accounting Officer at DYNAVAX TECHNOLOGIES CORP.

Action: appointed
Role: Vice President, Chief Accounting Officer

Exact text from the filing

On May 8, 2025, the Board of Directors of Dynavax Technologies Corporation (the “Company”) appointed Joseph Metzinger as the Company’s Vice President, Chief Accounting Officer, effective as of May 12, 2025 (the “Effective Date”).

View on SEC.gov

Source: SEC EDGAR

accession 0001029142-25-000081

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.